Sanofi Deal, PTV News: Jun 04, 2010




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Sanofi Deal, PTV News: Jun 04, 2010
Released on: June 04, 2010. © PharmaVentures Ltd
Visitors: You are watching a 1 minute preview.
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
  • Summary
  • Transcript
  • Participants
  • Company
French pharma giant in US$ 398M pre-clinical cancer agreement with Ascenta
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
Jansen Jacob
Analyst
PharmaVentures

Jansen’s expertise lies in transactions, business strategy & planning as well as market and competitor analysis. His skills include product and technology valuations, benchmarking, deal structuring and litigation support in the pharmaceutical sector. With over 15 years in the life science sector Jansen’s experience covers DNA therapeutics, immunotherapy, animal health and plant science research. Jansen holds a chemistry degree from Gandhiji University, a DPhil in Biochemistry from the University of Sussex and an MBA from Oxford Brookes University.
sanofi
Sanofi, headquartered in Paris, France, is a multinational pharmaceutical company, the world's fourth-largest by prescription sales. Sanofi engages in the research and development, manufacturing and marketing of pharmaceutical products for sale principally in the prescription market, but the firm also develops over-the-counter medication. Sanofi covers 7 major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines (it is the world's largest producer of the latter through its subsidiary sanofi pasteur).
Ascenta Therapeutics
Ascenta Therapeutics is a privately-held, clinical-stage biopharmaceutical company. It's primary focus is to develop new medicines to treat cancer patients.
PharmaVentures Ltd
PharmaVentures is a company that has proven success in deals and alliances.

PharmaVentures offers:


• Over 18 years of healthcare industry experience

• Experience gained from working with in excess of 1000 clients in 38 countries, and conducting more than 450 assignments

• Over 40 specialist advisors, analysts and researchers

• Skills honed in many countries - 80% of its business comes from outside the UK